In vitro assays demonstrated α-glucosidase inhibitory effect with an IC50 value of 0.165 mg/mL in glucose metabolism studies.
A novel polysaccharide (APNP) with a molecular weight of 3.56 × 10³ KDa and a total sugar content of 92.35 ± 0.07% was isolated from Pholiota nameko (T. Itô) S. Ito & S. Imai residue using alkaline extraction. Monosaccharide composition analysis revealed that APNP consisted of galactose, glucose, and mannose. FT-IR and NMR analysis results indicate that APNP form linkages between (1→3), (1→6), and (1→3,6)-β-D-glucose, (1→)-α-D-glucose, (1→)-α-D-galactose, and (1→3,6)-β-D-mannose. Thermogravimetric analysis revealed three distinct pyrolysis phases in APNP. Congo Red assay results indicated the absence of triple-helical conformation in APNP under weakly alkaline conditions. In vitro assays demonstrated α-glucosidase inhibitory activity of APNP, with an IC₅₀ value of 0.165 mg/mL. HepG2-IR insulin resistance model and Western blot analyses demonstrated APNP's ability to ameliorate insulin resistance and enhance glucose metabolism.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: